AB-PMJAY provides free hospital care to 7.4 crore patients: Centre
New Delhi: As of June 30, 2024, the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) has authorized 7.37 crore hospital admissions totalling ₹1 lakh crore, according to the latest data from the Ministry of Health. The scheme is active across 33 states and Union Territories.
According to an IANS report, the leading states in which Ayushman cards have been created under the PMJAY scheme include Madhya Pradesh with 402.5 lakh cards, Maharashtra (280 lakh), Karnataka (171.5 lakh) Jammu and Kashmir (85.9 lakh), Telangana (82.5 lakh), Tamil Nadu (73.6 lakh) and Meghalaya (19.76 lakh).
Beneficiaries eligible under the scheme can create their Ayushman card at any time throughout the year.
Eligible beneficiaries can either create the card themselves using Ayushman App or visit the nearest CSC or empanelled hospital to create their Ayushman card.
AB-PMJAY aims to provide health cover of Rs 5 lakh per family per year for secondary and tertiary care hospitalisation to approximately 55 crore beneficiaries corresponding to 12.34 crore families constituting the bottom 40 per cent of India’s population, according to official data.
Eligible beneficiaries can avail of cashless and paperless healthcare services related to hospitalisation across more than 29,000 empanelled hospitals in the country.
The cashless treatment covers all the costs related to treatment, medicines, supplies, diagnostic services, physician’s fees, room charges, surgeon charges, OT & ICU charges, etc.
The top speciality care treatments availed by beneficiaries to date are general medicine, infectious diseases, general surgery, medical oncology, ophthalmology and orthopaedics, according to the Health Ministry, IANS reported.
In the latest national master of the Health Benefit Package (HBP), the scheme provides cashless healthcare services related to 1,949 procedures across 27 medical specialities including General Medicine, Surgery, Cardiology, Oncology, etc.
Common procedures include hemodialysis, Covid-19 screening, and treatments for acute febrile illness.
The allocations for the PMJAY scheme in the Budget for 2024-25 allocation has been increased by 10 per cent to ₹7,300 crore from the revised estimate of ₹6,800 crore in 2023-24.
Overall, the Health Ministry's budget has been raised by 12.96 per cent to ₹90,958.63 crore, compared to ₹80,517.62 crore in the revised estimate for 2023-24.
As part of the healthcare package in the Budget, the government has also announced customs duty exemptions on three cancer treatment drugs -- Trastuzumab Deruxtecan, Osimertinib and Durvalumab. The move is aimed at reducing the cost of treatment for cancer patients.
Also Read:Delhi AIIMS directs to provide seamless healthcare services to AB-PMJAY beneficiaries
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.